KCNJ2
Inward rectifier potassium channel 2
Also known as: IRK1, KCNJ2_HUMAN, Kir2.1, LQT7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P63252
- Gene
- KCNJ2
- Ensembl
- ENSG00000123700
- Chromosome
- 17
- Canonical length
- 427 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Mutations in this gene have been associated with Andersen syndrome, which is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
427 residues, UniProt reviewed canonical sequence.
>P63252|KCNJ2
1 MGSVRTNRYS IVSSEEDGMK LATMAVANGF GNGKSKVHTR QQCRSRFVKK DGHCNVQFIN
61 VGEKGQRYLA DIFTTCVDIR WRWMLVIFCL AFVLSWLFFG CVFWLIALLH GDLDASKEGK
121 ACVSEVNSFT AAFLFSIETQ TTIGYGFRCV TDECPIAVFM VVFQSIVGCI IDAFIIGAVM
181 AKMAKPKKRN ETLVFSHNAV IAMRDGKLCL MWRVGNLRKS HLVEAHVRAQ LLKSRITSEG
241 EYIPLDQIDI NVGFDSGIDR IFLVSPITIV HEIDEDSPLY DLSKQDIDNA DFEIVVILEG
301 MVEATAMTTQ CRSSYLANEI LWGHRYEPVL FEEKHYYKVD YSRFHKTYEV PNTPLCSARD
361 LAEKKYILSN ANSFCYENEV ALTSKEEDDS ENGVPESTST DTPPDIDLHN QASVPLEPRP
421 LRRESEILocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNJ2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 34 nTPM
- heart muscle: 9.2 nTPM
- skeletal muscle: 9.1 nTPM
- tongue: 7.8 nTPM
- retina: 7.1 nTPM
- spleen: 6.9 nTPM
Single-cell type
- neutrophils: 313 nCPM
- oligodendrocytes: 159 nCPM
- retinal horizontal cells: 152 nCPM
- cardiomyocytes: 107 nCPM
- kupffer cells: 92 nCPM
- myonuclei: 74 nCPM
Immune cell
- neutrophil: 31 nTPM
- non-classical monocyte: 7.3 nTPM
- intermediate monocyte: 6.9 nTPM
- eosinophil: 5.6 nTPM
- basophil: 4.2 nTPM
- classical monocyte: 3.5 nTPM
Brain region
- white matter: 95 nTPM
- basal ganglia: 48 nTPM
- medulla oblongata: 48 nTPM
- pons: 47 nTPM
- midbrain: 42 nTPM
- thalamus: 39 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNJ2.
Disease | AllUniProt
Conditions KCNJ2 is implicated in, by any mechanism.
- Long QT syndrome 7 (LQT7) MIM:170390
- Short QT syndrome 3 (SQT3) MIM:609622
- Atrial fibrillation, familial, 9 (ATFB9) MIM:613980
Disease | GeneticClinVar
65 pathogenic / likely-pathogenic of 680 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Andersen Tawil syndrome
- Short QT syndrome type 3
- Congenital long QT syndrome
- Cardiovascular phenotype
- Atrial fibrillation, familial, 9
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0.31
- gnomAD missense Z
- 2.75
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle cell action potential involved in contraction
- cellular response to mechanical stimulus
- intracellular potassium ion homeostasis
- magnesium ion transport
- membrane depolarization during cardiac muscle cell action potential
- membrane repolarization during action potential
- membrane repolarization during cardiac muscle cell action potential
- positive regulation of potassium ion transmembrane transport
- potassium ion import across plasma membrane
- potassium ion transmembrane transport
- potassium ion transport
- protein homotetramerization
- regulation of cardiac muscle cell contraction
- regulation of heart rate by cardiac conduction
- regulation of membrane repolarization
- regulation of monoatomic ion transmembrane transport
- regulation of resting membrane potential
- relaxation of cardiac muscle
- relaxation of skeletal muscle
- regulation of skeletal muscle contraction via regulation of action potential
Molecular functions
- identical protein binding
- inward rectifier potassium channel activity
- phosphatidylinositol-4,5-bisphosphate binding
- voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Potassium channel, inwardly rectifying, Kir, cytoplasmic
- Potassium channel, inwardly rectifying, Kir, N-terminal
- Immunoglobulin E-set
- Potassium channel, inwardly rectifying, Kir
- Potassium channel, inwardly rectifying, transmembrane domain
- Inward rectifier potassium channel, C-terminal
- Inward rectifier potassium channel transmembrane domain
- Inward rectifier potassium channel N-terminal
- Inward rectifier potassium channel C-terminal domain
- Potassium channel, inwardly rectifying, Kir2.1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNJ2 as an antibody target. Whether an autoantibody or antibody against KCNJ2 could matter depends on whether native KCNJ2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNJ2 is annotated at the cell surface, where native KCNJ2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNJ2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...